Erudio Healtherudio.com
Drug
Filgrastim trials: what clinicians said in public
An HCP commentary report on 1 clinical trial studying filgrastim: COXEN. It covers what clinicians said in public about one trial, on podcasts, videos and posts, every statement linked to its source. Below them, 8 more trials with public commentary and no report yet.
| Trial | Indication | Phase | Statements | Sources | Size | Checked | Preview |
|---|---|---|---|---|---|---|---|
| COXEN NCT02177695 · SWOG Cancer Research Network | localized muscle-invasive bladder cancer | Phase 2 | 406 | 62 | Deep | Nov 1, 2026 | Preview |
| No report yetTrials with public commentary we haven't built a report for. Size is an estimate of the verified statements the commentary we've indexed so far will yield; final coverage is set when we build the report, within 24 hours of your confirmed order. You never pay more than quoted: a report delivered at a smaller size costs that size's price. Some can also be requested as a free preview. | |||||||
| S1826 NCT03907488 · National Cancer Institute (NCI) DeepView → | newly diagnosed advanced-stage classical Hodgkin lymphoma | Phase 3 | Deep | View | |||
| IMpassion031 NCT03197935 · Hoffmann-La Roche DeepView → | early-stage triple-negative breast cancer | Phase 3 | Deep | View | |||
| CALGB 50303 NCT00118209 · Alliance for Clinical Trials in Oncology DeepView → | untreated diffuse large B-cell lymphoma | Phase 3 | Deep | View | |||
| MK-3475A-D77 NCT05722015 · Merck Sharp & Dohme LLC StandardView → | first-line metastatic non-small cell lung cancer | Phase 3 | Standard | View | |||
| AHOD0431 NCT00302003 · Children's Oncology Group FocusedView → | newly diagnosed low-risk childhood Hodgkin lymphoma | Phase 3 | Focused | View | |||
| P3BEP NCT02582697 · University of Sydney FocusedView → | intermediate and poor-risk metastatic germ cell tumors | Phase 3 | Focused | View | |||
| AHOD0831 NCT01026220 · Children's Oncology Group FocusedView → | Not given | Phase 3 | Focused | View | |||
| OPTIMUM NCT03188172 · University of Leeds FocusedView → | high-risk multiple myeloma and plasma cell leukemia | Phase 2 | Focused | View | |||